Virios Therapeutics Inc News - VIRI | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Virios Therapeutics Inc (VIRI)
Virios Therapeutics Inc (VIRI) News

Virios Therapeutics Inc (VIRI)

0.187

0.007

(3.89%)

Closed 29 September 6:00AM

Delayed by 15 minutes

0.1804

-0.0066

(-3.53%)

After Hours: 9:12AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

- Top-line results from the ongoing investigator-initiated Bateman Horne Center Long-COVID phase 2 featuring...

Form 8-K - Current report

Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a...

Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID

- New patent would extend coverage and expand potential value of Virios’ antiviral pipeline globally –...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

ATLANTA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

LowFloatLopes

LowFloatLopes 2 weeks ago

FYI it’s still summer lol 4 more days …

maq1214

maq1214 2 weeks ago

Just one month away from a Reverse split, Thank you Mr Greg Duncan you are a mastermind in this. What happened to the destined partnership for Phase 3 Fibromyalgia, even given a commencing date of summer 2024- I guess it all lies, no one should trust this moron

maq1214

maq1214 2 months ago

Why greg Duncan stretching a lot of news such as partnership of fibromyalgia and Long covid data? feels like reverse split is imminent

georgie18

georgie18 2 months ago

VIRI...1947...Back in here on the Double Bottom...🥳

Gold prospector

Gold prospector 2 months ago

Exactly, my biggest fear is no volume and the shorts push it down

DavidLeeRoth

DavidLeeRoth 2 months ago

I hope you’re right bud! We’ll all know before the middle of October. VIRI LONG💰

Gold prospector

Gold prospector 2 months ago

maq1214

maq1214 2 months ago

Happy Monday to all. What's happening with VIRI? feels like RS is happening sooner than later

maq1214

maq1214 2 months ago

I hope so. been holding 150 thousand shares, total gamble

DavidLeeRoth

DavidLeeRoth 2 months ago

I believe we move above $1/share without a RS. VIRI LONG💰

maq1214

maq1214 2 months ago

News expected October. Compliance deadline is 28th October. Do you reckon we avoid a reverse split ?

DavidLeeRoth

DavidLeeRoth 2 months ago

VIRI NEWS!!

https://ir.virios.com/news/press-releases/detail/120/virios-therapeutics-announces-completion-of-enrollment-in

DavidLeeRoth

DavidLeeRoth 2 months ago

Nice $37,000 BID for a Friday morning😉 VIRI LONG💰

DavidLeeRoth

DavidLeeRoth 2 months ago

What?🤣😆 VIRI LONG💰💰

maq1214

maq1214 2 months ago

very disappointed atm :(

gail

gail 2 months ago

if it keeps dipping, i may get back in.

DavidLeeRoth

DavidLeeRoth 2 months ago

Multiple dollars could come quickly here folks!! VIRI LONG💰

DavidLeeRoth

DavidLeeRoth 2 months ago

I’m sure you will be fine😎 They drop some IMC-1 phase 3 partnership news, and we’re off to the races!!💰

gail

gail 2 months ago

looks like i should have waited, lol

gail

gail 2 months ago

hi cj! i just grabbed some pre market.

DavidLeeRoth

DavidLeeRoth 2 months ago

Gotta be!! Over 7 million traded now, and hit .39 earlier.😎

Carjockey2

Carjockey2 2 months ago

News coming????

DavidLeeRoth

DavidLeeRoth 2 months ago

6 million shares already traded premarket!! Let’s go VIRI😎💰

👍️ 1 💯 1

Golden Cross

Golden Cross 2 months ago

$trong AH's 💲💲💲

DavidLeeRoth

DavidLeeRoth 2 months ago

VIRI up over 22%. Partnership news could be dropping folks!!

DavidLeeRoth

DavidLeeRoth 2 months ago

Up 10% with some nice ASK slapping!! News leak??

maq1214

maq1214 3 months ago

if this holds above the resistance, uptrend incoming !

maq1214

maq1214 3 months ago

thought we were expecting results by the summer or August. I guess there are still enrolling, anyone has any information about this?

Dr. Lucinda Bateman is the Principal Investigator for a phase 2 randomized placebo-controlled #clinicaltrial of valacyclovir plus celecoxib for the treatment of #LongCOVID.
🧪This trial needs to enroll an additional 10 women with #LongCOVID to participate. Link in comments. pic.twitter.com/AyG850tCxR— Bateman Horne Center (@BatemanHorne) July 3, 2024

Klinsmann

Klinsmann 3 months ago

Has been nice 50% gains…

skydog526

skydog526 3 months ago

This will go back into the toilet, then RS. The promo pump fest on stocktwits is over. No worries I've got plenty of shares of this garbage like you all.

DavidLeeRoth

DavidLeeRoth 3 months ago

I’m pretty sure we can do much better than $1😎 VIRI LONG💰

JUST 10-11-12

JUST 10-11-12 3 months ago

DavidLeeRoth

DavidLeeRoth 3 months ago

TEAM VIRI getting noticed😎💰

Virios is pleased that Maxim Group has initiated research coverage with its first research report by analyst Jason McCarthy. Note: Analyst research is conducted independently of the company, and Virios does not endorse or adopt the views expressed in any analyst research report.— Virios Therapeutics (@ViriosBiotech) June 20, 2024

DavidLeeRoth

DavidLeeRoth 3 months ago

Hi everyone, I like what I heard today, as IMC-2 is being well tolerated by patients, and IMC-1 sounds like it may be attractive for a partnership going into phase 3, and it sounds like we are definitely going to get to $1 without a R/S. This is all just IMO of course, but I’m adding more😎

Smarkel

Smarkel 3 months ago

What they said?

DavidLeeRoth

DavidLeeRoth 3 months ago

Meeting just ended, and it sure does sound like VIRIOS will be trading above $1 without a reverse split before October 28th😎 VIRI LONG💰

DavidLeeRoth

DavidLeeRoth 3 months ago

Don’t forget the meeting tomorrow at 1100 folks!! VIRI💰

https://ir.virios.com/

Klinsmann

Klinsmann 3 months ago

Toute est possible…

maq1214

maq1214 4 months ago

Can this regain compliance organically before the deadline of October ?

DavidLeeRoth

DavidLeeRoth 4 months ago

8-K out. VIRI💰

Nasdaq extension until October 28, 2024.

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001818844/000155837024009066/viri-20240611x8k.htm

glenn1919

glenn1919 4 months ago

VIRI......................https://stockcharts.com/h-sc/ui?s=VIRI&p=W&b=5&g=0&id=p86431144783

valleybenedetto

valleybenedetto 4 months ago

Smart this is the demand zone. Kick it into supply zone. 👍

longrichard

longrichard 4 months ago

LOL

Buy signal. Reloading.

valleybenedetto

valleybenedetto 4 months ago

The chances of that are pretty strong unfortunately.

maq1214

maq1214 4 months ago

rest assured it sadly is

JUST 10-11-12

JUST 10-11-12 4 months ago

valleybenedetto

valleybenedetto 4 months ago

They got themselves out now they will drop a research report and company needs to bring tangible news.

DavidLeeRoth

DavidLeeRoth 4 months ago

I figured it would have tanked if someone was selling that many shares. Seems like something different is happening.🤷‍♂️

valleybenedetto

valleybenedetto 4 months ago

The funder just pumped himself out of stock. Plain and simple.

DavidLeeRoth

DavidLeeRoth 4 months ago

Virios Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions